Latest China Startup Funding Rounds
Startup funding in China: recent rounds, the companies behind them and their participating investors.
- Rounds
- 84 Jan 1 – Oct 17, 2026
- Disclosed funding
- $4.9B 29 disclosed amounts
- Median round
- $72.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| 子 子午线光年 is a Beijing company developing world-model AI technology. | Undisclosed | AngelSeed | AI | China | Investors | |
| BT Beyang TherapeuticsCompany profile AI-driven drug discovery company using its ExCEED molecular design platform AI-driven drug discovery company using its ExCEED molecular design platform | $30M | Series A | Biotech | China | Investors | |
| L LatentVerseCompany profile LatentVerse develops foundation models that combine perception, prediction and robot action. LatentVerse develops foundation models that combine perception, prediction and robot action. | Undisclosed | Seed | Robotics | China | Investors | |
| S SiengineCompany profile Chinese semiconductor company developing automotive cockpit and intelligent-driving chips for passenger and commercial vehicles. Chinese semiconductor company developing automotive cockpit and intelligent-driving chips for passenger and commercial vehicles. | Undisclosed | Series C+ | Hardware | China | Investors | |
| DI Delta IntelligenceCompany profile Delta Intelligence develops foundation models and data-collection tools for humanoid robots to understand space and coordinate whole-body movement. Delta Intelligence develops foundation models and data-collection tools for humanoid robots to understand space and coordinate whole-body movement. | ~CN¥500M | Angel++Seed | Robotics | China | Investors Undisclosed | |
| TP Torrey Pines MedicineCompany profile Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases | Undisclosed | Pre-SeedPre-seed | Biotech | China | Investors | |
| YT Yimu TechnologyCompany profile Yimu Technology develops sensing hardware and AI systems for interaction with the physical world. Yimu Technology develops sensing hardware and AI systems for interaction with the physical world. | >CN¥1B | Series ESeries C+ | Robotics | China | Investors Undisclosed | |
| M MoSense builds flexible tactile skin and sensing systems for robots. | Undisclosed | AngelUndisclosed | Robotics | China | Investors | |
| TK Tian Keyu AI labCompany profile AI research venture founded by Keyu Tian, developing multimodal foundation models for visual prediction. AI research venture founded by Keyu Tian, developing multimodal foundation models for visual prediction. | Undisclosed | Early financingUndisclosed | AI | China | Investors | |
| DF Drug FarmCompany profile Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases | $55M | Series DSeries C+ | Biotech | China | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1HSG
Anew Labs, Math Magic, Full-Life Technologies
7rounds1led - 2IDG Capital
Anew Labs, Apex Intelligence, InfiMaker
7rounds2led - 3Qiming Venture Partners
Vivacta Biotechnology, Pulnovo Medical, Vivatides Therapeutics
7rounds—led - 4GL Ventures
Anew Labs, 子午线光年, LatentVerse
6rounds1led - 5HongShan
子午线光年, MoSense, Litchibot
5rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.